ES8609297A1 - Procedimiento de preparar aminolactonas - Google Patents

Procedimiento de preparar aminolactonas

Info

Publication number
ES8609297A1
ES8609297A1 ES546140A ES546140A ES8609297A1 ES 8609297 A1 ES8609297 A1 ES 8609297A1 ES 546140 A ES546140 A ES 546140A ES 546140 A ES546140 A ES 546140A ES 8609297 A1 ES8609297 A1 ES 8609297A1
Authority
ES
Spain
Prior art keywords
compound
formula
yield
image
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES546140A
Other languages
English (en)
Other versions
ES546140A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceutical Works PLC
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Richter Gedeon Vegyeszeti Gyar RT
Biogal Gyogyszergyar Rt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar RT, Biogal Gyogyszergyar Rt filed Critical Richter Gedeon Vegyeszeti Gyar RT
Publication of ES8609297A1 publication Critical patent/ES8609297A1/es
Publication of ES546140A0 publication Critical patent/ES546140A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30Oxygen atoms, e.g. delta-lactones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

PROCEDIMIENTO PARA AMINOLACTONAS. COMPRENDE: A) REDUCIR A UN COMPUESTO DE FORMULA (II) CON BOROHIDRURO SODICO, ENTRE 0 Y 40JC Y EN PRESENCIA DE UN ACIDO ALCANCARBOXILICO QUE TIENE UNA CADENA ALQUENILICA INTERIOR; Y B) TRATAR AL COMPUESTO OBTENIDO EN A) CON ACIDO CLORHIDRICO ACUOSO CONCENTRADO, PARA OBTENER UN COMPUESTO DE FORMULA (I). SIENDO: R, UN GRUPO ALQUILO DE C 1 A 6. SE UTILIZA COMO INTERMEDIO EN LA SINTESIS GLOBAL DEL ANTIBIOTICO TIENAMICONA Y DE COMPUESTOS RELACIONADOS CON EL MISMO.
ES546140A 1984-08-15 1985-08-14 Procedimiento de preparar aminolactonas Expired ES8609297A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU309084A HU194203B (en) 1984-08-15 1984-08-15 Process for producing amino-lactone

Publications (2)

Publication Number Publication Date
ES8609297A1 true ES8609297A1 (es) 1986-09-01
ES546140A0 ES546140A0 (es) 1986-09-01

Family

ID=10962501

Family Applications (1)

Application Number Title Priority Date Filing Date
ES546140A Expired ES8609297A1 (es) 1984-08-15 1985-08-14 Procedimiento de preparar aminolactonas

Country Status (10)

Country Link
JP (1) JPS61246176A (es)
BE (1) BE903069A (es)
CH (1) CH666686A5 (es)
DE (1) DE3529159A1 (es)
ES (1) ES8609297A1 (es)
FR (1) FR2569194B3 (es)
GB (1) GB2163160A (es)
HU (1) HU194203B (es)
PT (1) PT80959B (es)
SE (1) SE453193B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8531638D0 (en) * 1985-12-23 1986-02-05 Ici Plc Chemical compounds
ATE384038T1 (de) 2002-10-18 2008-02-15 Tohru Yokozawa Verfahren zur herstellung optisch aktiver aminoalkohole
WO2007086076A2 (en) * 2006-01-24 2007-08-02 Unichem Laboratories Limited An improved process for preparation of leflunomide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4287123A (en) * 1980-01-14 1981-09-01 Merck & Co., Inc. Synthesis of thienamycin via (3SR, 4RS)-3-((RS)-1-acyloxyethyl)-2-oxo-4-azetidineacetate
US4360684A (en) * 1981-04-08 1982-11-23 Merck & Co., Inc. Process for the preparation of (2S)-tetrahydro-2α-methyl-6-oxo-4βα-carboxylic acid

Also Published As

Publication number Publication date
HU194203B (en) 1988-01-28
SE453193B (sv) 1988-01-18
PT80959A (en) 1985-09-01
ES546140A0 (es) 1986-09-01
BE903069A (fr) 1986-02-14
FR2569194A1 (fr) 1986-02-21
HUT37777A (en) 1986-02-28
FR2569194B3 (fr) 1987-06-26
GB8520403D0 (en) 1985-09-18
SE8503811L (sv) 1986-02-16
PT80959B (en) 1987-02-06
CH666686A5 (de) 1988-08-15
DE3529159A1 (de) 1986-02-27
GB2163160A (en) 1986-02-19
SE8503811D0 (sv) 1985-08-14
JPS61246176A (ja) 1986-11-01

Similar Documents

Publication Publication Date Title
ES2000603A6 (es) Un procedimiento para preparar aril-piperidino carbinoles
EP0547825A3 (en) Process for producing alpha-ketoamide derivative
JPS6466189A (en) Production of penicillanic acid derivative
CS909186A2 (en) Zpusob vyroby chinolinkarboxylovych kyselin
ES8609297A1 (es) Procedimiento de preparar aminolactonas
EP0315973A3 (en) Sialocylglycerolipids and method for preparing the same
ZA822759B (en) Manufacture of quaternary ammonium compounds
JPS57192392A (en) Production of 3-alkoxymethylcephalosporin
ES8206535A1 (es) Un metodo mejorado para producir un compuesto de 7-aminoce- fem.
AU8309591A (en) Process for producing aminomethanephosphonic acid and aminomethylphosphinic acids
HUT37444A (en) Process for preparing bestatin derivatives
DE59406746D1 (de) Verfahren zur herstellung von schwefelsäurehalbestern
EP0739885A4 (en) METHOD FOR PRODUCING 3-ISOXAZOLE CARBONIC ACID
TNSN88070A1 (fr) Procede de preparation de l'acide (pyridyl-3)-3-1h, 3h-pyrrolo (1,2-c) thiazolecarboxylique-7dextrogyre
CA1273347C (es)
AU3368093A (en) Process for producing prostaglandin E
MY105720A (en) Process for penems.
JPS56125325A (en) Preparation of omega-hydroxy coenzyme q1 derivative
EP0251327A3 (en) Process for production of anthracycline compound r2ox2
HUT36682A (en) Fungicide preparatives consisting of 2,2-dichlor-/cis/-3-metil-/trans/3-chlor-metil cyclopropane-methanol and process for production of the compound
ES8400741A1 (es) Procedimiento para la preparacion de un derivado de dibenzoxepinona.
ES8303315A1 (es) "procedimiento para la preparacion de 4-metilmercapto-2-acetoxi-butiraldehido".
JPS56158728A (en) Stabilizing method of monosubstituted malonic acid derivative
SE8106254L (sv) Forfarande for framstellning av alkyletrar
JPS56125393A (en) Preparation of cefamandole